About BioAge Labs
BioAge Labs builds in the biotech category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.
What they do: BIOAGE targets aging to develop drugs that treat severe diseases Biotech
Funding context: Andreessen Horowitz, $170M Series D in 2024
Recent milestones:
- BioAge Labs appears in the 100Xfounder startup directory import feed.
Why it Matters
BioAge Labs matters because bIOAGE targets aging to develop drugs that treat severe diseases Biotech
Funding Snapshot
- Series D | Andreessen Horowitz, $170M Series D in 2024
Hiring Roles
This company is actively hiring.
Meet the Founders

BioAge Labs Team
Founder & CEO

